What Tectonic Therapeutic, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 3 | 11 |
| Total trades | 10 | 37 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 86 | 205,939 |
| Disposed | 4,067 | 38,401 |
| Net activity | −3,981 | +167,538 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| McNamara Peter | Chief Scientific Officer | Sep 30 | Open-market sale · S | −536 | $23.04 | −$12.3K | 54,305 |
| Lochner Daniel | Chief Financial Officer | Sep 25 | Withheld — tax / exercise cost · F | −520 | $23.67 | −$12.3K | 58,024 |
| McNamara Peter | Chief Scientific Officer | Sep 25 | Withheld — tax / exercise cost · F | −444 | $23.67 | −$10.5K | 54,841 |
| Reicin Alise | Chief Executive Officer | Sep 25 | Withheld — tax / exercise cost · F | −1,545 | $23.67 | −$36.6K | 309,078 |
| Ruddy Marcella K. | Chief Medical Officer | Sep 25 | Withheld — tax / exercise cost · F | −525 | $23.67 | −$12.4K | 67,157 |
| Schwabish Marc | Chief Business Officer | Sep 25 | Withheld — tax / exercise cost · F | −411 | $23.67 | −$9.73K | 44,903 |
| McNamara Peter | Chief Scientific Officer | Aug 25 | Open-market sale · S | −43 | $36.52 | −$1.57K | 55,285 |
| McNamara Peter | Chief Scientific Officer | Aug 25 | Exercise / conversion · M | +43 | $14.71 | +$633 | 55,328 |
| McNamara Peter | Chief Scientific Officer | Aug 12 | Exercise / conversion · M | +43 | $14.71 | +$633 | 55,328 |
| McNamara Peter | Chief Scientific Officer | Aug 12 | Open-market sale · S | −43 | $35.00 | −$1.51K | 55,285 |
| McNamara Peter | Chief Scientific Officer | Jun 30 | Open-market sale · S | −172 | $35.00 | −$6.02K | 55,285 |
| McNamara Peter | Chief Scientific Officer | Jun 30 | Exercise / conversion · M | +172 | $14.71 | +$2.53K | 55,457 |
| Reicin Alise | Chief Executive Officer | Jun 20 | Withheld — tax / exercise cost · F | −924 | $30.34 | −$28K | 310,623 |
| Ruddy Marcella K. | Chief Medical Officer | May 04 | Open-market sale · S | −1,065 | $30.00 | −$32K | 67,682 |
| Ruddy Marcella K. | Chief Medical Officer | Apr 01 | Open-market sale · S | −1,000 | $31.05 | −$31.1K | 68,747 |
| McNamara Peter | Chief Scientific Officer | Mar 06 | Open-market sale · S | −215 | $35.00 | −$7.53K | 55,285 |
| McNamara Peter | Chief Scientific Officer | Mar 06 | Open-market sale · S | −6,047 | $30.00 | −$181K | 55,500 |
| McNamara Peter | Chief Scientific Officer | Mar 06 | Exercise / conversion · M | +215 | $14.71 | +$3.16K | 61,547 |
| McNamara Peter | Chief Scientific Officer | Mar 06 | Exercise / conversion · M | +2,500 | $2.38 | +$5.95K | 61,332 |
| Ruddy Marcella K. | Chief Medical Officer | Mar 06 | Open-market sale · S | −10,000 | $30.00 | −$300K | 69,747 |
Loading...
